NCT03750331

Brief Summary

Transplant Centers are facing new organisational challenges with regards to the growing number of patients they have to follow-up. We have developed and assessed the feasibility of using a novel web application permitting a medically-tailored follow-up of stable renal transplanted outpatients: Ap'TELECARE. This novel approach is likely to facilitate the organization of patients' follow-up at the Transplant Centre level as well as to provide secondary individual benefits in terms of therapeutic education, adherence to treatment and eventually to improve long term outcome.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
738

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
24 days until next milestone

Study Start

First participant enrolled

December 17, 2018

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

4.8 years

First QC Date

November 8, 2018

Last Update Submit

January 15, 2025

Conditions

Keywords

telemedicine

Outcome Measures

Primary Outcomes (1)

  • Patients experiencing at least one episode of graft dysfunction

    graft dysfunction defined by a drop of at least 20% of their usual estimated Glomerular Filtration Rate (eGFR) value)

    2 years

Secondary Outcomes (9)

  • Failure of immunosuppressive treatment

    2 years

  • number of patients who needed to return to dialysis

    2 years

  • number of patients with acute or chronic transplant rejection

    2 years

  • Post-transplant complication

    2 years

  • Death

    2 years

  • +4 more secondary outcomes

Study Arms (2)

traditional patient follow-up

ACTIVE COMPARATOR

a group of renal transplant outpatients consulting their Transplant Centre following a traditional schedule (every other week up to 6 months post-transplant, once a month up to year 1, every three months up to year 2 and every 6 months thereafter)

Other: traditional schedule

medically-tailored follow-up with Ap'Telecare

EXPERIMENTAL

a group of patients assisted by Ap'Telecare and consulting their Transplant Centre following a less stringent schedule of consultations (every month up to 6 months, every other month up to year 1, every six months up to year 2 and once a year thereafter).

Other: Ap'Telecare

Interventions

an internet application on a computer, tablet or smartphone

medically-tailored follow-up with Ap'Telecare

a group of renal transplant outpatients consulting their Transplant Centre following a traditional schedule

traditional patient follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients transplanted for at least 3 months
  • Stable renal graft function

You may not qualify if:

  • No home internet access
  • Major disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clermont-Ferrand, CHU Site Gabriel-Montpied

Clermont-Ferrand, France

Location

CHU Saint-Etienne

Saint-Etienne, France

Location

Study Officials

  • Christophe Mariat, MD PhD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Non-inferiority Randomized Controlled Trial comparing Non-inferiority Randomized Controlled Trial comparing (i) a group of renal transplant outpatients consulting their Transplant Centre following a traditional schedule (every other week up to 6 months post-transplant, once a month up to year 1, every three months up to year 2 and every 6 months thereafter) to (ii) a group of patients assisted by Ap'TELACARE and consulting their Transplant Centre following a less stringent schedule of consultations (every month up to 6 months, every other month up to year 1, every six months up to year 2 and once a year thereafter).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 23, 2018

Study Start

December 17, 2018

Primary Completion

October 10, 2023

Study Completion

December 1, 2025

Last Updated

January 16, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations